Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The malignant phenotype is largely the consequence of dysregulated gene expression. Transformed cells depend upon not just a global increase in protein synthesis but an altered translational landscape in which pro-oncogenic mRNAs are translationally up-regulated. Such mRNAs have been shown to possess longer and more structured 5′-UTRs requiring high levels of eukaryotic initiation factor 4A (eIF4A) helicase activity for efficient translation. As such there is a developing focus on targeting eIF4A as a cancer therapy. In order for such treatments to be successful, we must develop a detailed understanding of the mechanisms which make specific mRNAs more dependent on eIF4A activity than others. It is also crucial to fully characterize the potentially distinct roles of eIF4A1 and eIF4A2, which until recently were thought to be functionally interchangeable. This review will highlight the recent advances made in this field that address these issues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The RNA helicase eIF4A unwinds the complex 5′ UTR structures of cap-dependent transcripts and is a critical component of the eIF4F translational complex (10, 17).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [17]
Citations
Cites
Ji, P., Diederichs, S., Wang, W., Böing, S., Metzger, R., Schneider, P. M., Tidow, N., Brandt, B., Buerger, H., Bulk, E., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206928 · Cited by 2,189
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
An RNA G-quadruplex in the 5′ UTR of the NRAS proto-oncogene modulates translation
Kumari, S., Bugaut, A., Huppert, J. L., & Balasubramanian, S. (2007) · Nature Chemical Biology · doi:10.1038/nchembio864 · Cited by 822
Targeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799
The Scanning Mechanism of Eukaryotic Translation Initiation
Hinnebusch, A. G. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035802 · Cited by 798
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006) · Science · doi:10.1126/science.1130276 · Cited by 731
5'-UTR RNA G-quadruplexes: translation regulation and targeting
Bugaut, A., & Balasubramanian, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks068 · Cited by 642
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Wolfe, A. L., Singh, K., Zhong, Y., Drewe, P., Rajasekhar, V. K., Sanghvi, V. R., Mavrakis, K. J., Jiang, M., Roderick, J. E., Van der Meulen, J., et al. (2014) · Nature · doi:10.1038/nature13485 · Cited by 635
Pestova, T. V., & Kolupaeva, V. G. (2002) · Genes & Development · doi:10.1101/gad.1020902 · Cited by 566
Hsieh, A. C., Costa, M., Zollo, O., Davis, C., Feldman, M. E., Testa, J. R., Meyuhas, O., Shokat, K. M., & Ruggero, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.021 · Cited by 434
G-quadruplexes: the beginning and end of UTRs
Huppert, J. L., Bugaut, A., Kumari, S., & Balasubramanian, S. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn511 · Cited by 429
Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
Pelletier, J., Graff, J., Ruggero, D., & Sonenberg, N. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2789 · Cited by 367
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A
Bordeleau, M.-E., Mori, A., Oberer, M., Lindqvist, L., Chard, L. S., Higa, T., Belsham, G. J., Wagner, G., Tanaka, J., & Pelletier, J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio776 · Cited by 366
Rogers, G. W., Richter, N. J., & Merrick, W. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12236 · Cited by 335
Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Mediated Gene Regulation
Meijer, H. A., Kong, Y. W., Lu, W. T., Wilczynska, A., Spriggs, R. V., Robinson, S. W., Godfrey, J. D., Willis, A. E., & Bushell, M. (2013) · Science · doi:10.1126/science.1231197 · Cited by 326
Yan, L. X., Wu, Q. N., Zhang, Y., Li, Y. Y., Liao, D. Z., Hou, J. H., Fu, J., Zeng, M. S., Yun, J. P., Wu, Q. L., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2803 · Cited by 323
eIF4A3 is a novel component of the exon junction complex
CHAN, C. C., DOSTIE, J., DIEM, M. D., FENG, W., MANN, M., RAPPSILBER, J., & DREYFUSS, G. (2004) · RNA · doi:10.1261/rna.5230104 · Cited by 292
Millevoi, S., Moine, H., & Vagner, S. (2012) · WIREs RNA · doi:10.1002/wrna.1113 · Cited by 277
5′-UTR G-quadruplex structures acting as translational repressors
Beaudoin, J.-D., & Perreault, J.-P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq557 · Cited by 255
Inhibition of Eukaryotic Translation Initiation by the Marine Natural Product Pateamine A
Low, W.-K., Dang, Y., Schneider-Poetsch, T., Shi, Z., Choi, N. S., Merrick, W. C., Romo, D., & Liu, J. O. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.008 · Cited by 250
Nielsen, P. J., & Trachsel, H. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03049.x · Cited by 231
Inhibition of translation in living eukaryotic cells by an RNA G-quadruplex motif
Arora, A., Dutkiewicz, M., Scaria, V., Hariharan, M., Maiti, S., & Kurreck, J. (2008) · RNA · doi:10.1261/rna.1001708 · Cited by 229
A comparison of DNA and RNA quadruplex structures and stabilities
Joachimi, A., Benz, A., & Hartig, J. S. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.08.043 · Cited by 228
Bordeleau, M.-E., Matthews, J., Wojnar, J. M., Lindqvist, L., Novac, O., Jankowsky, E., Sonenberg, N., Northcote, P., Teesdale-Spittle, P., & Pelletier, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504249102 · Cited by 228
Rubio, C. A., Weisburd, B., Holderfield, M., Arias, C., Fang, E., DeRisi, J. L., & Fanidi, A. (2014) · Genome Biology · doi:10.1186/s13059-014-0476-1 · Cited by 200
RNA Quadruplex-Based Modulation of Gene Expression
Wieland, M., & Hartig, J. S. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.06.005 · Cited by 198
c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation
Lin, C.-J., Cencic, R., Mills, J. R., Robert, F., & Pelletier, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5876 · Cited by 180
Pateamine: a potent cytotoxin from the New Zealand Marine sponge, mycale sp.
Northcote, P. T., Blunt, J. W., & Munro, M. H. G. (1991) · Tetrahedron Letters · doi:10.1016/0040-4039(91)80182-6 · Cited by 179
MicroRNAs Trigger Dissociation of eIF4AI and eIF4AII from Target mRNAs in Humans
Fukao, A., Mishima, Y., Takizawa, N., Oka, S., Imataka, H., Pelletier, J., Sonenberg, N., Thoma, C., & Fujiwara, T. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.005 · Cited by 178
Modelska, A., Turro, E., Russell, R., Beaton, J., Sbarrato, T., Spriggs, K., Miller, J., Gräf, S., Provenzano, E., Blows, F., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.542 · Cited by 172
Self-citationPolier, G., Neumann, J., Thuaud, F., Ribeiro, N., Gelhaus, C., Schmidt, H., Giaisi, M., Köhler, R., Müller, W. W., Proksch, P., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.012 · Cited by 166
Shahid, R., Bugaut, A., & Balasubramanian, S. (2010) · Biochemistry · doi:10.1021/bi100957h · Cited by 161
RNA-Mediated Sequestration of the RNA Helicase eIF4A by Pateamine A Inhibits Translation Initiation
Bordeleau, M.-E., Cencic, R., Lindqvist, L., Oberer, M., Northcote, P., Wagner, G., & Pelletier, J. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.10.005 · Cited by 161
Zhang, A. Y. Q., Bugaut, A., & Balasubramanian, S. (2011) · Biochemistry · doi:10.1021/bi200805j · Cited by 152
Li, Q., Imataka, H., Morino, S., Rogers, G. W., Richter-Cook, N. J., Merrick, W. C., & Sonenberg, N. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7336 · Cited by 152
The p46 subunit of eukaryotic initiation factor (eIF)-4F exchanges with eIF-4A.
Yoder-Hill, J., Pause, A., Sonenberg, N., & Merrick, W. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53358-5 · Cited by 140
Trinucleotide repeats in human genome and exome
Kozłowski, P., de Mezer, M., & Krzyżosiak, W. J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq127 · Cited by 140
Selective Pharmacological Targeting of a DEAD Box RNA Helicase
Lindqvist, L., Oberer, M., Reibarkh, M., Cencic, R., Bordeleau, M.-E., Vogt, E., Marintchev, A., Tanaka, J., Fagotto, F., Altmann, M., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001583 · Cited by 132
Predictable suppression of gene expression by 5′-UTR-based RNA quadruplexes
Halder, K., Wieland, M., & Hartig, J. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp696 · Cited by 129
A cellular response linking eIF4AI activity to eIF4AII transcription
Galicia-Vázquez, G., Cencic, R., Robert, F., Agenor, A. Q., & Pelletier, J. (2012) · RNA · doi:10.1261/rna.033209.112 · Cited by 119
Davis, M. A. M., Olson, K. J., Dallaire, P., Major, F., Assmann, S. M., & Bevilacqua, P. C. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq804 · Cited by 111
Kuznetsov, G., Xu, Q., Rudolph-Owen, L., TenDyke, K., Liu, J., Towle, M., Zhao, N., Marsh, J., Agoulnik, S., Twine, N., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1026 · Cited by 105
Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia
Tsumuraya, T., Ishikawa, C., Machijima, Y., Nakachi, S., Senba, M., Tanaka, J., & Mori, N. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.025 · Cited by 101
Mauro, V. P., & Edelman, G. M. (2007) · Cell Cycle · doi:10.4161/cc.6.18.4739 · Cited by 98
An RNA Hairpin to G-Quadruplex Conformational Transition
Bugaut, A., Murat, P., & Balasubramanian, S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja308665g · Cited by 93
Ebada, S. S., Lajkiewicz, N., Porco, J. A., Li-Weber, M., & Proksch, P. (2011) · Fortschritte der Chemie organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products · doi:10.1007/978-3-7091-0748-5_1 · Cited by 92
An mRNA-rRNA base-pairing mechanism for translation initiation in eukaryotes
Dresios, J., Chappell, S. A., Zhou, W., & Mauro, V. P. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1031 · Cited by 85
Małgowska, M., Gudanis, D., Kierzek, R., Wyszko, E., Gabelica, V., & Gdaniec, Z. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku710 · Cited by 69
Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A
Cencic, R., Robert, F., Galicia-Vázquez, G., Malina, A., Ravindar, K., Somaiah, R., Pierre, P., Tanaka, J., Deslongchamps, P., & Pelletier, J. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.25 · Cited by 66
Williams-Hill, D. M., Duncan, R. F., Nielsen, P. J., & Tahara, S. M. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9804 · Cited by 64
Single-Molecule Kinetics of the Eukaryotic Initiation Factor 4AI upon RNA Unwinding
Sun, Y., Atas, E., Lindqvist, L. M., Sonenberg, N., Pelletier, J., & Meller, A. (2014) · Structure · doi:10.1016/j.str.2014.04.014 · Cited by 56
Liang, S., Zhou, Y., Chen, Y., Ke, G., Wen, H., & Wu, X. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000152 · Cited by 55
Matveeva, O. V., & Shabalina, S. A. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.4.1007 · Cited by 51
Davis, M. A. M., Assmann, S. M., & Bevilacqua, P. C. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2096255 · Cited by 51
Progress in the Chemistry of Organic Natural Products Vol. 94
Kinghorn, A. D., Kobayashi, J., & Falk, H. (2011) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-7091-0748-5 · Cited by 47
Downregulation of EIF4A2 in Non–Small-Cell Lung Cancer Associates with Poor Prognosis
Xi, S., Juanjuan, Y., Yalan, T., He, P., Jianzhong, L., & Wu, Q.-N. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.04.011 · Cited by 42
Impact of genomic stability on protein expression in endometrioid endometrial cancer
Lomnytska, M. I., Becker, S., Gemoll, T., Lundgren, C., Habermann, J. K., Olsson, A., Bodin, I., Engström, U., Hellman, U., Hellman, K., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.67 · Cited by 37
Pánek, J., Kolář, M., Vohradský, J., & Valášek, L. S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt548 · Cited by 29
Panopoulos, P., & Mauro, V. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804904200 · Cited by 18
Regulation of Eukaryotic Initiation Factor 4AII by MyoD during Murine Myogenic Cell Differentiation
Galicia-Vázquez, G., Marco, S. D., Lian, X. J., Ma, J. F., Gallouzi, I., & Pelletier, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087237 · Cited by 15
Cited by
Cancer the‘RBP’eutics–RNA-binding proteins as therapeutic targets for cancer
Mohibi, S., Chen, X., & Zhang, J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.07.001 · Cited by 199
Aptamers: Uptake mechanisms and intracellular applications
Yoon, S., & Rossi, J. J. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.003 · Cited by 169
Tailor made: the art of therapeutic mRNA design
Metkar, M., Pepin, C. S., & Moore, M. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00827-x · Cited by 178
Wanted DEAD/H or Alive: Helicases Winding Up in Cancers
Cai, W., Chen, Z. X., Rane, G., Singh, S. S., Choo, Z., Wang, C., Yuan, Y., Tan, T. Z., Arfuso, F., Yap, C. T., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw278 · Cited by 119
Wilczynska, A., Gillen, S. L., Schmidt, T., Meijer, H. A., Jukes-Jones, R., Langlais, C., Kopra, K., Lu, W.-T., Godfrey, J. D., Hawley, B. R., et al. (2019) · Genome Biology · doi:10.1186/s13059-019-1857-2 · Cited by 62
Self-citation
Metadata
- Authors
- Raza, F., Waldron, J. A., & Quesne, J. L.
- Affiliations
- Medical Research Council (GB)
- Medical Research Council Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, U.K.
- Corresponding author
- Raza, Farheen
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2015-11-27
- Volume
- 43
- Issue
- 6
- Pages
- 1227-1233
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W2179151406
- Cited by
- 61
- References
- 60
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 7 · 2023: 10 · 2022: 4 · 2021: 10 · 2020: 6 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 1
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Society Transactions (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- eIF4A, eIF4A1, EIF4A2, translation initiation
- MeSH terms
- Benzofurans, Epoxy Compounds, Humans, Neoplasms, Sterols, Thiazoles, Protein Biosynthesis, Triterpenes, Gene Expression Regulation, Neoplastic, Macrolides, Protein Isoforms, Eukaryotic Initiation Factor-4A, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.